Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Serum Galectin-3 Level as an Indicator of Subclinical Inflammation in Patients With Familial Mediterranean Fever

NCT06451471 is registered in ClinicalTrials.gov with Turkish League Against Rheumatism as lead sponsor.

NCT NCT06451471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06451471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Serum Galectin-3 Level as an Indicator of Subclinical Inflammation in Patients With Familial Mediterranean Fever
Lead sponsor
Turkish League Against Rheumatism
Phase
Observational
Overall status
Completed
Start date
May 1, 2021
Completion date
November 1, 2022
Enrollment
154 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ailesel akdeniz ateşi